Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Soluble TREM2 is elevated in Parkinson’s disease subgroups with increased CSF tau

Brain(2020)10.1093/brain/awaa021Source: DataRank Database

Soluble TREM2 is elevated in Parkinson’s disease subgroups with increased CSF tau is a research paper published in Brain (2020). On theSindex it has a DataRank of 0. It has been cited 104 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access104 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (13 grants)Impact (FWCI 5.33)OA: bronzeTopics (36)Linked Datasets (12)DataCite Reuse (12)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (18)

Michelle S. Swarovski ORCID,Patricia Linortner,Marian Shahid ORCID,Abigail J. Zuckerman ORCID,Qian Wang ORCID

Live enrichment

PubMed:32065223 PMC:PMC7089668 OpenAlex:https://openalex.org/W3006954961

Stanford Medicine Dean’s Postdoctoral Fellowship

Grant: P50 AG047366

NINDS

Grant: P50 NS062684

NIA

Grant: RF1AG053001

NIH

Grant: K23 NS075097

NIH

Grant: R01 NS115114

Michael J. Fox Foundation

Grant: 6440.0

NIA NIH HHS

Grant: P30 AG066515

NIA NIH HHS

Grant: U24 AG021886

NCATS NIH HHS

Grant: UL1 TR002369

Pacific Udall Center

Scully Research Initiative

NIH

Jean Perkins Foundation

FWCI

5.33

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

bronzeLicense: https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model

journalhttps://academic.oup.com/brain/article-pdf/143/3/932/32963580/awaa021.pdf

publisherhttps://academic.oup.com/brain/article-pdf/143/3/932/32963580/awaa021.pdf

publisherhttp://academic.oup.com/brain/article-pdf/143/3/932/32963580/awaa021.pdf

journalhttps://doi.org/10.1093/brain/awaa021

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32065223

Fields of Study

Neuroinflammation and Neurodegeneration MechanismsInflammation biomarkers and pathwaysConducting polymers and applications

MeSH Terms

AgedCross-Sectional StudiesDementiaFemaleHumansMaleMembrane GlycoproteinsMiddle AgedParkinson DiseaseReceptors, ImmunologicBiomarkersAmyloid beta-Peptidestau ProteinsCognitive Dysfunction

Keywords

BiomarkerDementiaParkinson's diseaseDiseaseTREM2MedicineCognitive declinePopulationAlzheimer's diseaseInternal medicinePsychologyPathologyOncologyMicrogliaBiologyInflammationCerebrospinal fluidTauParkinson’s Disease

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer’s disease

10.6084/m9.figshare.21547384.v1figshare

Additional file 1 of Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer’s disease

10.6084/m9.figshare.21547384figshare

Additional file 2 of Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer’s disease

10.6084/m9.figshare.21547387.v1figshare

Additional file 2 of Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer’s disease

10.6084/m9.figshare.21547387figshare

Additional file 3 of Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer’s disease

10.6084/m9.figshare.21547390.v1figshare

Additional file 3 of Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer’s disease

10.6084/m9.figshare.21547390figshare

Additional file 4 of Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer’s disease

10.6084/m9.figshare.21547393.v1figshare

Additional file 4 of Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer’s disease

10.6084/m9.figshare.21547393figshare

Additional file 5 of Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer’s disease

10.6084/m9.figshare.21547396.v1figshare

Additional file 5 of Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer’s disease

10.6084/m9.figshare.21547396figshare

Additional file 1 of The longitudinal trajectory of CSF sTREM2: the alzheimer’s disease neuroimaging initiative

10.6084/m9.figshare.26739390.v1figshare

Additional file 1 of The longitudinal trajectory of CSF sTREM2: the alzheimer’s disease neuroimaging initiative

10.6084/m9.figshare.26739390figshare

Related Papers (10)

Alzheimer's disease‐associated TREM2 variants exhibit either decreased or increased ligand‐dependent activation

Alzheimer s & Dementia(2016)

OpenAlex related

10.1016/j.jalz.2016.07.004

Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2

Molecular Neurodegeneration(2014)

OpenAlex related

10.1186/1750-1326-9-20

DAP12 Stabilizes the C-terminal Fragment of the Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) and Protects against LPS-induced Pro-inflammatory Response

Journal of Biological Chemistry(2015)

OpenAlex related

10.1074/jbc.m115.645986

TREM2 in Alzheimer’s Disease: Microglial Survival and Energy Metabolism

Frontiers in Aging Neuroscience(2018)

OpenAlex related

10.3389/fnagi.2018.00395

Cerebrospinal fluid sTREM2 in Alzheimer’s disease: comparisons between clinical presentation and AT classification

Scientific Reports(2020)

OpenAlex related

10.1038/s41598-020-72878-8

Non-pathological roles of microglial TREM2/DAP12: TREM2/DAP12 regulates the physiological functions of microglia from development to aging

Neurochemistry International(2020)

OpenAlex related

10.1016/j.neuint.2020.104878

Investigation of pathology, expression and proteomic profiles in human TREM2 variant postmortem brains with and without Alzheimer’s disease

Brain Pathology(2020)

OpenAlex related

10.1111/bpa.12842

Neurodegenerative disease and TREM2

Rinsho Shinkeigaku(2014)

OpenAlex related

10.5692/clinicalneurol.54.1122

P1‐127: Assessing Trem2 Risk Variants in Alzheimer's Disease with RNA‐SEQ

Alzheimer s & Dementia(2016)

OpenAlex related

10.1016/j.jalz.2016.06.875

[O2–13–06]: ASSESSING TREM2 FUNCTION IN ALZHEIMER's DISEASE WITH RNA‐SEQ

Alzheimer s & Dementia(2017)

OpenAlex related

10.1016/j.jalz.2017.07.221

Soluble TREM2 is elevated in Parkinson’s disease subgroups with increased CSF tau

FAIR Checklist

Authors (18)

Funding (13 grants)

Impact

Open Access

Topics

Linked Datasets (12)

Annotations (Europe PMC)

Related Papers (10)